Guohong Yan
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
10-Hydroxy-2-decenoic Acid, a Bioactive Component of Royal Jelly, Induces p53-Mediated Apoptosis in Cholangiocarcinoma In Vitro and In Vivo.
Journal: European journal of pharmacology
Published: December 20, 2025
RRx-001 inhibits G6PD to deplete NADPH and trigger disulfidptosis coupled with DAMP-mediated immunogenic cell death in hepatocellular carcinoma.
Journal: Cell death discovery
Published: September 23, 2025
Pan-cancer analysis of HOMER1 in hepatocellular carcinoma revealing diagnostic potential and immune landscape with experimental validation.
Journal: Discover oncology
Published: July 11, 2025
Structural characterization and functional role of SLC7A6 in GSSG transport and Ferroptosis regulation.
Journal: International journal of biological macromolecules
Published: June 06, 2025
Pan-cancer analysis identifies DBF4B as an immunologic and prognostic biomarker.
Journal: Journal of Cancer
Published: December 20, 2024
2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione from Averrhoa carambola L. roots: Suppressing hepatocellular carcinoma progression through ROS accumulation and p53 pathway-mediated apoptosis.
Journal: Toxicology and applied pharmacology
Published: December 10, 2024
Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis.
Journal: Clinical and experimental medicine
Published: October 25, 2024
Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma.
Journal: Scientific reports
Published: October 13, 2024
Anti-tumor and anti-metastatic effects of RRx-001 on hepatocellular carcinoma: mechanisms of action and therapeutic potential.
Journal: Frontiers in pharmacology
Published: July 24, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026